Us Automated Insulin Delivery Systems Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Automated Insulin Delivery Systems Market was valued at USD 4.5 Billion in 2022 and is projected to reach USD 11.2 Billion by 2030, growing at a CAGR of 12.5% from 2024 to 2030.
The U.S. Automated Insulin Delivery Systems Market is experiencing significant growth, driven by technological advancements and a rising prevalence of diabetes. In 2024, the market was valued at approximately USD 5.20 billion and is projected to reach around USD 9.81 billion by 2033, expanding at a Compound Annual Growth Rate (CAGR) of 7.3% during this period.
Automated insulin delivery systems, often referred to as "artificial pancreas" devices, integrate continuous glucose monitoring (CGM) with insulin pumps to automatically adjust insulin delivery based on real-time glucose readings. This innovation aims to maintain optimal blood glucose levels with minimal user intervention, enhancing the quality of life for individuals with diabetes.
Several key players are leading the charge in this market:
Insulet Corporation: Known for its Omnipod system, Insulet has seen robust growth. In the third quarter of 2024, the company reported a 26% increase in sales, totaling $543.9 million. This surge is attributed to the successful international launch of the Omnipod 5 insulin pump and FDA clearance for use in type 2 diabetes patients.
Medtronic: A pioneer in medical technology, Medtronic offers the MiniMed series of insulin pumps. In August 2024, the company received FDA approval for its Simplera CGM, a disposable, all-in-one device designed to simplify diabetes management. This approval is expected to bolster Medtronic's position in the automated insulin delivery market.
Tandem Diabetes Care: With its t:slim X2 insulin pump featuring Control-IQ technology, Tandem integrates seamlessly with CGM systems to provide automated insulin adjustments. The company's commitment to innovation has solidified its presence in the U.S. market.
Market growth is further propelled by the increasing adoption of CGM devices, which are essential components of automated insulin delivery systems. Companies like Dexcom have established partnerships with insulin pump manufacturers to enhance system integration. For instance, Dexcom's collaboration with Tandem Diabetes Care allows for seamless data sharing between devices, optimizing insulin delivery and glucose control.
Despite the promising advancements, challenges persist. Inventory management remains a critical issue, as evidenced by Insulet's $13.5 million charge for unutilized inventory in the second quarter of 2024. Such pressures highlight the need for efficient supply chain strategies to meet the dynamic demands of the market.
In summary, the U.S. Automated Insulin Delivery Systems Market is poised for substantial growth, driven by technological innovations and strategic collaborations among key industry players. As these systems become more integrated and user-friendly, they offer the potential to significantly improve diabetes management and patient outcomes.
Get an In-Depth Research Analysis of the Global Automated Insulin Delivery Systems Market Size And Forecast [2025-2032]
Eli Lily
Tandem
Insulet
Big Foot Biomedical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Automated Insulin Delivery Systems Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Automated Insulin Delivery Systems Market
Insulin Pumps
Continuous Glucose Monitors (CGMs)
Hybrid Closed-Loop Systems
Automated Insulin Delivery Software
Wearable Devices
Sensor-augmented Pump Systems
Threshold-Suspend Systems
Full Closed-Loop Systems
Bluetooth-enabled Devices
Artificial Pancreas Devices
Hospitals and Clinics
Homecare Settings
Diabetes Specialty Clinics
Research and Academic Institutions
Long-term Care Facilities
External Insulin Delivery Systems
Implantable Insulin Delivery Systems
Disposable Systems
Reusables
Smart Insulin Pens
Type 1 Diabetes Management
Type 2 Diabetes Management
Gestational Diabetes Management
Pediatric Diabetes Care
Emergency Hypoglycemia Management
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Automated Insulin Delivery Systems Market Research Analysis
1. Introduction of the Global Automated Insulin Delivery Systems Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Automated Insulin Delivery Systems Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Automated Insulin Delivery Systems Market, By Type
6. Global Automated Insulin Delivery Systems Market, By Application
7. Global Automated Insulin Delivery Systems Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Automated Insulin Delivery Systems Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/